|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 232.3 INR | -4.99% |
|
-26.48% | -19.00% |
Sun Pharma Advanced Research Company Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 239.5 million compared to INR 284.6 million a year ago. Revenue was INR 341.4 million compared to INR 286.4 million a year ago.
Net loss was INR 953.5 million compared to INR 823.5 million a year ago. Basic loss per share from continuing operations was INR 2.94 compared to INR 3.03 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -19.00% | 951M | |
| +32.73% | 664B | |
| +29.29% | 567B | |
| -7.07% | 354B | |
| +19.19% | 330B | |
| +4.36% | 286B | |
| +13.38% | 234B | |
| +5.15% | 199B | |
| -9.78% | 196B | |
| -4.94% | 148B |
SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED 
